SUSAN MAYKISH: Open Payments
NPI 1861491102 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 43 payments from 14 companies in 2025. Trend: 2023 $1,051 · 2024 $708 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $180 |
| Lilly USA, LLC | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 6 | $90 |
| PFIZER INC. | 5 | $82 |
| ABBVIE INC. | 4 | $67 |
| Abbott Laboratories | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Exact Sciences Corporation | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Ozempic, BREZTRI, Wegovy, MOUNJARO, FREESTYLE LIBRE 3, SHINGRIX, JARDIANCE, PREVNAR 20.
Industry payments across NJ — which companies pay providers there.
